Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Diagnostic Biochips Market Report 2022: Micro-electrode-dot Array (MEDA) Biochips Presents Opportunities | ||
By: PR Newswire Association LLC. - 24 Nov 2022 | Back to overview list |
|
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Technological Innovations and Growth Opportunities in Diagnostic Biochips" report has been added to ResearchAndMarkets.com's offering. Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the associated biomolecules will help in the development of accurate diagnostics and aid precision medicine. Yet the high number of molecules often requires multiple tests or bulky instruments. To overcome this need, diagnostic biochip technology offers a miniaturized multiplexing sensing platform. A biochip is a solid substrate with a multitude of miniaturized test sites that have immobilized probes to capture and detect the target biomolecules. While biochips can have several applications, current research focuses on diagnostic biochips. The huge demand for precision medicine and low-cost point-of-care diagnostic platforms will drive the market. However, key players must focus on reducing the costs of DNA and protein biochips, meeting regulatory standards, and increasing awareness among users. The global diagnostic biochips industry is advancing, offering new fluidic control technologies, probe immobilization techniques, signal detection technologies, and data analytics. As they can detect different kinds of biomolecules, innovative diagnostic biochips provide growth opportunities for genetic testing, cancer diagnostics and therapy, infectious diseases management, chronic disease management, allergy panel testing, and drug testing. This study focuses on DNA biochips, protein biochips, and microfluidic biochips. The key elements of this analysis include an overview of the global diagnostic biochips industry supported by the following:
Key Topics Covered: 1. Strategic Imperatives 2. Growth Opportunity Analysis
3. Technology Analysis: DNA Biochips
4. Technology Analysis: Protein Biochips
5. Technology Analysis: Microfluidic Biochips
6. Innovation Indicators
7. Patent Analysis
8. Growth Opportunity Universe
9. Key Industry Participants 10. Appendix 12. Next Steps For more information about this report visit https://www.researchandmarkets.com/r/iai2a0 Media Contact: Research and Markets
For E.S.T Office Hours Call +1-917-300-0470
U.S. Fax: 646-607-1907 Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-diagnostic-biochips-market-report-2022-micro-electrode-dot-array-meda-biochips-presents-opportunities-301686721.html SOURCE Research and Markets |
||
|
||
Copyright 2022 PR Newswire Association LLC. | Back to overview list |